Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.

Bradley JD; Sugawara S; Lee KH; Ostoros G; Demirkazik A; Zemanova M; Sriuranpong V; Zimmer Gelatti AC; Janoski de Menezes J; Zurawski B; Newton M; Chander P; Jia N; Bielecka ZF; Özgüroğlu M

doi:10.1200/JCO-25-03012

← 뒤로

Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.

0/5 보강

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 📖 저널 OA 34.8% 2022~2026 2026 Vol.44(5) p. 429

Bradley JD, Sugawara S, Lee KH, Ostoros G, Demirkazik A, Zemanova M

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Bradley JD, Sugawara S, et al. (2026). Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(5), 429. https://doi.org/10.1200/JCO-25-03012

MLA Bradley JD, et al.. "Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 44, no. 5, 2026, pp. 429.

PMID 41499719 ↗

DOI 10.1200/JCO-25-03012

같은 제1저자의 인용 많은 논문 (1)

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025